Topiramate / phentermine - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Topiramate and topiramate/phentermine combination: New restrictions to prevent exposure during pregnancy

Key facts

• Active substance:
  • Topiramate
  • phentermine
• Therapeutic area (MeSH):
  • Epilepsy
  • Migraine Disorders
• Procedure number:
  EMEA/H/A-31/1520
• Regulatory outcome:
  Variation
• DHPC type:
  Restriction of indication
• Referral name:
  Topiramate
• Human ATC codes:
  N03AX11
• Dissemination date:
  01/11/2023